These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22271863)

  • 1. Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
    Chew WK; Segarra I; Ambu S; Mak JW
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1762-8. PubMed ID: 22271863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model.
    Abdel-Wahab AA; Shafey DA; Selim SM; Sharaf SA; Mohsen KK; Allam DM; Elkhadry SW; Gouda MA
    Parasitol Res; 2024 Jul; 123(7):286. PubMed ID: 39046555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts.
    Chew WK; Wah MJ; Ambu S; Segarra I
    Exp Parasitol; 2012 Jan; 130(1):22-5. PubMed ID: 22027550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
    Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
    Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary observation on the development and dynamic changes of chronic toxoplasmosis in mice].
    Zhou G; Bai S; Li Y; Zhu G; Huang S
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Jun; 36(3):304-309. PubMed ID: 38952318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex dichotomy in the course of experimental latent toxoplasmosis.
    Hegazy MM; Elmehankar MS; Azab MS; El-Tantawy NL; Abdel-Aziz A
    Exp Parasitol; 2019 Jul; 202():15-21. PubMed ID: 31078550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
    Suzuki N; Espinas FM; Sakurai H; Saito A; Sasaki H; Kato G; Manba K; Taniguchi K; Mochizuki K; Osaki H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):367-80. PubMed ID: 6730783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
    Wei HX; Wei SS; Lindsay DS; Peng HJ
    PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.
    Djurković-Djaković O; Nikolić A; Bobić B; Klun I; Aleksić A
    Microbes Infect; 2005 Jan; 7(1):49-54. PubMed ID: 15716077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis.
    FarahatAllam A; Shehab AY; Fawzy Hussein Mogahed NM; Farag HF; Elsayed Y; Abd El-Latif NF
    Heliyon; 2020 Apr; 6(4):e03661. PubMed ID: 32322704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Nigella sativa oil- and wheat germ oil-loaded metal organic frameworks on chronic murine toxoplasmosis.
    Mohammad OS; El Naggar HM; Abdelmaksoud HF; Barakat AM; Abdelhameed RM; Shehata MAS
    Acta Trop; 2023 Mar; 239():106823. PubMed ID: 36608751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.
    Allam AF; Hagras NA; Farag HF; Osman MM; Shalaby TI; Kazem AH; Shehab AY; Mogahed NMFH
    J Parasit Dis; 2022 Mar; 46(1):166-177. PubMed ID: 35299902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
    Mady RF; El-Temsahy MM; Issa YA; Zaghloul AS; Khedr SI
    Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimodality therapeutic application on Toxoplasma gondii encephalitis utilizing Spiramycin and 'de novo' Ferula asafetida in immunodeficient mice.
    Almurshidi BH; Fahmy Z; El-Shennawy A; Selim EAH; Hammam OA; Okasha H; Al-Hajj W; Mahmoud SA; Abuelenain GL
    Parasite Immunol; 2023 Dec; 45(12):e13014. PubMed ID: 37807942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights on the therapeutic effect of levamisole on the chronic toxoplasmosis in mice model.
    Zoghroban HS; Elmansory BM; Issa YA; Eltokhy AK; Abo Safia HS; El Maghraby GM; Salama AM
    Exp Parasitol; 2023 May; 248():108515. PubMed ID: 36958594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
    Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.
    Montazeri M; Mehrzadi S; Sharif M; Sarvi S; Shahdin S; Daryani A
    Parasitol Res; 2018 Oct; 117(10):3045-3057. PubMed ID: 30088074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2',3'-dideoxyinosine on Toxoplasma gondii cysts in mice.
    Sarciron ME; Lawton P; Saccharin C; Petavy AF; Peyron F
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1531-6. PubMed ID: 9210679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis.
    Chorlton SD
    Med Hypotheses; 2019 Dec; 133():109376. PubMed ID: 31472369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylactic effects of trimethoprim-sulfamethoxazole in Toxoplasma-infected mice].
    Lee YH; Lee DY; Shin DW
    Korean J Parasitol; 1993 Dec; 31(4):363-70. PubMed ID: 8297894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.